eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Drug Development for Chronic Fatigue Syndrome and Myalgic Encephalomyelitis; Public Workshop
Drug Development for Chronic Fatigue Syndrome and Myalgic Encephalomyelitis; Public Workshop
Document ID:
FDA-2012-N-0962-0004
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2013-05562
View Document:
Details Information
Document Subtype:
Notice of Meeting
Received Date:
March 11 2013, at 12:00 AM Eastern Daylight Time
Start-End Page:
15371 - 15373
Page Count:
3
Comment Start Date:
March 11 2013, at 12:00 AM Eastern Standard Time
Comment Due Date:
April 8 2013, at 11:59 PM Eastern Standard Time
Comments
View All
Total:
54
Leigh P Prim - Comment
Posted:
04/15/2013
ID:
FDA-2012-N-0962-0011
Comment Period Closed
Aug 02,2013 11:59 PM ET
Cheryl Marshall - Comment
Posted:
04/16/2013
ID:
FDA-2012-N-0962-0042
Comment Period Closed
Aug 02,2013 11:59 PM ET
Teri Jackson - Comment
Posted:
04/16/2013
ID:
FDA-2012-N-0962-0025
Comment Period Closed
Aug 02,2013 11:59 PM ET
Sandra Myron - Comment
Posted:
04/17/2013
ID:
FDA-2012-N-0962-0043
Comment Period Closed
Aug 02,2013 11:59 PM ET
Lisa A Kavanaugh - Comment
Posted:
04/15/2013
ID:
FDA-2012-N-0962-0006
Comment Period Closed
Aug 02,2013 11:59 PM ET
Related Documents
Total:
0
No documents available.
Drug Development for Chronic Fatigue Syndrome and Myalgic Encephalomyelitis; Public Workshop
Details Information
Comments
View AllPosted: 04/15/2013 ID: FDA-2012-N-0962-0011
Aug 02,2013 11:59 PM ET
Posted: 04/16/2013 ID: FDA-2012-N-0962-0042
Aug 02,2013 11:59 PM ET
Posted: 04/16/2013 ID: FDA-2012-N-0962-0025
Aug 02,2013 11:59 PM ET
Posted: 04/17/2013 ID: FDA-2012-N-0962-0043
Aug 02,2013 11:59 PM ET
Posted: 04/15/2013 ID: FDA-2012-N-0962-0006
Aug 02,2013 11:59 PM ET
Related Documents